Printer Friendly

NANCY BRINKER APPOINTED TO CAREMARK BOARD; STARTED SUSAN G. KOMEN BREAST CANCER FOUNDATION

 NORTHBROOK, Ill., Oct. 20 /PRNewswire/ -- Caremark International (NYSE: CK) today announced Nancy Brinker has been appointed to the company's board of directors. Brinker founded the Dallas-based Susan G. Komen Breast Cancer Foundation, the fourth largest U.S. funding organization for breast cancer research. Since its inception in 1982, the foundation has raised more than $20 million to help detect the causes of the disease and identify a cure.
 An author and public speaker, Brinker is a long-time participant in government panels and advisory groups on breast cancer and women's health issues. Most recently, she has been named a member of the integration panel helping guide a $200 million breast cancer study sponsored by the U.S. Army's Medical Research and Development Command.
 Also this year, Brinker has joined the advisory committee of the National Women's Health Initiative, which with the National Institutes of Health is undertaking a 15-year, $600 million study of some 160,000 women. The biggest women's health prevention study in the United States, it will focus on heart disease, breast cancer and osteoporosis, the leading causes of death among women.
 As a member of the President's Cancer Panel, Brinker has chaired a subpanel examining and analyzing breast cancer research, detection and treatment worldwide.
 Caremark chairman and chief executive officer Lance Piccolo said Brinker's leadership role in generating financial resources to solve breast cancer and advancing public education about its prevalence and dangers will make her an excellent contributor to the board of directors, which now numbers 13.
 "Nancy Brinker's dedication epitomizes Caremark's commitment to making a difference in the lives and future of the people we care for, including thousands of patients with cancer," Piccolo said. "We also share her great interest in promoting women's health care. Caremark looks forward to the leadership, direction and support she will bring us."
 Over the last decade, Brinker has guided the non-profit Susan G. Komen Breast Cancer Foundation's evolution, supervising all aspects of its operation, including the award of more than 170 grants. She has also managed the organization of a several-thousand-member volunteer auxiliary to assist in fundraising. Additionally, Brinker has been responsible for a number of national events and initiatives to increase understanding of breast cancer and support for those fighting it.
 It 1990, Brinker created a 34-city walk/run, "Race for the Cure." Beginning in 1987, she spurred a technology transfer alliance between the University of Texas Southwest Medical School Cancer Program, Baylor Medical Center and the Susan G. Komen Foundation to forge new links between laboratory and clinic and promote more advanced, systematic care. And from 1986 to 1992, as a National Cancer Advisory Board member, in concert with the National Cancer Institute, she chaired public hearings on breast cancer and generated a special report to the president.
 Caremark International is a leading provider of alternate site health care. The company markets a broad range of therapies and services to patients, physicians, providers and payors, and works as a partner in managed care delivery systems. Caremark had 1992 sales of $1.46 billion.
 -0- 10/20/93
 /CONTACT: Steve Mazur of Caremark International, 708-559-4696/
 (CK)


CO: Caremark International ST: Illinois IN: HEA SU: PER

TS -- NY023 -- 4406 10/20/93 09:09 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 20, 1993
Words:536
Previous Article:TEAMQUEST ANNOUNCES AVAILABILITY OF CAPACITY MANAGEMENT FACILITY BASELINE 5.1
Next Article:BAXTER INTERNATIONAL REPORTS THIRD-QUARTER RESULTS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters